Skip to main content
Log in

Medicolegal aspects of tetrazepam metabolism

  • Original Article
  • Published:
International Journal of Legal Medicine Aims and scope Submit manuscript

Abstract

The benzodiazepine tetrazepam is primarily muscle relaxant with comparably lower central sedating effects and is therefore commonly prescribed for muscle spasms of different origins. To evaluate tetrazepam metabolism, a study was conducted with ten healthy volunteers. Blood and urine samples were regularly collected after the intake of 50 mg tetrazepam. Toxicological analyses revealed that tetrazepam is also metabolized to diazepam and further to nordazepam, which has not yet been reported. Tetrazepam and diazepam could be detected in urine samples at least 72 h after intake, the diazepam concentration being 33% (±14% SD), on average, of the tetrazepam concentration. On the basis of three case histories, the importance of the detection of these newly described metabolites is shown as necessary to prevent false accusations and potential negative legal consequences for examined persons.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Keane PE, Simiand J, Morre M, Biziere K (1988) Tetrazepam: a benzodiazepine which dissociates sedation from other benzodiazepine activities. I. Psychopharmacological profile in rodents. J Pharmacol Exp Ther 245:692–698

    PubMed  CAS  Google Scholar 

  2. Keane PE, Bachy A, Morre M, Biziere K (1988) Tetrazepam: a benzodiazepine which dissociates sedation from other benzodiazepine activities. II. In vitro and in vivo interactions with benzodiazepine binding sites. J Pharmacol Exp Ther 245:699–705

    PubMed  CAS  Google Scholar 

  3. Milanov I (1992) Mechanisms of tetrazepam action on spasticity. Acta Neurol Belg 92:5–15

    PubMed  CAS  Google Scholar 

  4. Lobisch M, Schaffler K, Wauschkuhn H, Nickel B (1996) Clinical pilot study of the myogenic effects of flupirtine in comparison to tetrazepam and placebo (in German). Arzneimittelforschung 46:293–298

    PubMed  CAS  Google Scholar 

  5. Simiand J, Keane PE, Biziere K, Soubrie P (1989) Comparative study in mice of tetrazepam and other centrally active skeletal muscle relaxants. Arch Int Pharmacodyn Ther 297:272–285

    PubMed  CAS  Google Scholar 

  6. Perez-Guerrero C, Suarez J, Herrera MD, Marhuenda E (1997) Vasodilating effects of tetrazepam in isolated vascular smooth muscles: comparison with cromakalim and diltiazem. Pharmacol Res 36:237–242

    Article  PubMed  CAS  Google Scholar 

  7. Pellkofer M, Paulig M (1989) Comparative double-blind study of the effectiveness and tolerance of baclofen, tetrazepam and tizanidine in spastic movement disorders of the lower extremities (in German). Med Klin (Munich) 84:5–8

    CAS  Google Scholar 

  8. Rote Liste (2005) Tetrazepam. Rote Liste Win 2005/II version 4.2 Rote Liste Service GmbH

  9. Baumgartner MG, Cautreels W, Langenbahn H (1984) Biotransformation and pharmacokinetics of tetrazepam in man. Arzneimittelforschung 34:724–729

    PubMed  CAS  Google Scholar 

  10. Dussy FE, Hamberg C, Briellmann TA (2005) Quantification of benzodiazepines in whole blood and serum. Int J Legal Med Oct 12:1–8

    Google Scholar 

  11. Maurer H, Pfleger K (1987) Identification and differentiation of benzodiazepines and their metabolites in urine by computerized gas chromatography–mass spectrometry. J Chromatogr 422:85–101

    Article  PubMed  CAS  Google Scholar 

  12. Staak M, Sticht G, Saternus KS, Kaferstein H (1982) Pharmacokinetic studies following administration of tetrazepam in rhesus monkeys. Beitr Gerichtl Med 40:323–328

    PubMed  CAS  Google Scholar 

  13. Bun H, Philip F, Berger Y, Necciari J, Al Mallah NR, Serradimign A, Cano JP (1987) Plasma levels and pharmacokinetics of single and multiple dose of tetrazepam in healthy volunteers. Arzneimittelforschung 37:199–202

    PubMed  CAS  Google Scholar 

  14. Staak M, Sticht G, Kaferstein H, Norpoth T (1984) Pharmacokinetics and metabolite pattern of tetrazepam and chlordesmethyldiazepam. Beitr Gerichtl Med 42:75–79

    PubMed  CAS  Google Scholar 

  15. Schulz M, Schmoldt A (2003) Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics. Pharmazie 58:447–474

    PubMed  CAS  Google Scholar 

  16. Geister U, Gaupp M, Arnold P, Schaarschmidt D, Doser K (2000) Bioavailability investigation of two different oral formulations of tetrazepam. Arzneimittelforschung 50:328–332

    PubMed  CAS  Google Scholar 

  17. Concheiro M, Villain M, Bouchet S, Ludes B, Lopez-Rivadulla M, Kintz P (2005) Windows of detection of tetrazepam in urine, oral fluid, beard, and hair, with a special focus on drug-facilitated crimes. Ther Drug Monit 27:565–570

    Article  PubMed  CAS  Google Scholar 

  18. Musshoff F, Dettmeyer R, Madea B (1998) Death in the bathtub—rectal drug administration. Arch Kriminol 201:80–86

    PubMed  CAS  Google Scholar 

  19. Boccardi G, Deleuze C, Gachon M, Palmisano G, Vergnaud JP (1992) Autoxidation of tetrazepam in tablets: prediction of degradation impurities from the oxidative behavior in solution. J Pharm Sci 81:183–185

    Article  PubMed  CAS  Google Scholar 

  20. Hammad MA, Muller BW (1998) Solubility and stability of tetrazepam in mixed micelles. Eur J Pharm Sci 7:49–55

    Article  PubMed  CAS  Google Scholar 

  21. Guengerich FP (1991) Reactions and significance of cytochrome P-450 enzymes. J Biol Chem 266:10019–10022

    PubMed  CAS  Google Scholar 

  22. Porter TD, Coon MJ (1991) Cytochrome P-450. Multiplicity of isoforms, substrates, and catalytic and regulatory mechanisms. J Biol Chem 266:13469–13472

    PubMed  CAS  Google Scholar 

  23. Schütz H (1989) Benzodiazepines II. A handbook, 1st edn. Springer, Berlin Heidelberg New York, p 32

    Google Scholar 

  24. He YA, Roussel F, Halpert JR (2003) Analysis of homotropic and heterotropic cooperativity of diazepam oxidation by CYP3A4 using site-directed mutagenesis and kinetic modeling. Arch Biochem Biophys 409:92–101

    Article  PubMed  CAS  Google Scholar 

  25. Steentoft A, Worm K, Pedersen CB, Sprehn M, Mogensen T, Sorensen MB, Nielsen E (1996) Drugs in blood samples from unconscious drug addicts after the intake of an overdose. Int J Legal Med 108:248–251

    Article  PubMed  CAS  Google Scholar 

  26. Kaa E, Teige B (1993) Drug-related deaths during the 1980s. A comparative study of drug addict deaths examined at the institutes of forensic medicine in Aarhus, Denmark and Oslo, Norway. Int J Legal Med 106:5–9

    Article  PubMed  CAS  Google Scholar 

  27. Favretto D, Frison G, Maietti S, Ferrara SD (2006) LC-ESI-MS/MS on an ion trap for the determination of LSD, iso-LSD, nor-LSD and 2-oxo-3-hydroxy-LSD in blood, urine and vitreous humor. Int J Legal Med (in press) DOI 10.1007/s00414-006-0078-x

Download references

Acknowledgements

The authors would like to thank Dr. Herbert Oberacher for valuable discussions and Mrs. Elisabeth Unterdorfer and Mr. Karl-Heinz Pramstrahler for their technical support within the laboratory.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Walter Rabl.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pavlic, M., Libiseller, K., Grubwieser, P. et al. Medicolegal aspects of tetrazepam metabolism. Int J Legal Med 121, 169–174 (2007). https://doi.org/10.1007/s00414-006-0118-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00414-006-0118-6

Keywords

Navigation